ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today celebrated the …
Uncategorized
Decisions, decisions: Subspecialty training in ophthalmology
Like all physicians, ophthalmologists undergo extensive training.After years of learning skills as an undergraduate, in medical school and continuing into residency, they then have a choice to make: begin their career or continue their training in a su…
Uncategorized
Excimer laser trabeculostomy reduces IOP at 24 months
COPENHAGEN, Denmark — A combined phaco-excimer laser trabeculostomy procedure helped lower IOP in patients with glaucoma, according to a study presented at the European Society of Cataract and Refractive Surgeons meeting.Alice Grise-Dulac, MD, of Hôpit…
Uncategorized
Women in medicine often fill ‘unrecognized and uncompensated’ leadership roles
Women physicians often take on mentorship roles rather than “institutionally recognized leadership positions,” but there are solutions that may help level the playing field, according to experts.Although the presence of women in U.S. medical schools ha…
Uncategorized
Physicians who stay after residency may be more difficult to retain
CHICAGO — Institutions that struggle to retain physicians after residency may benefit from encouraging attending physicians and staffers to view new graduates as emerging independent practitioners rather than as students.How institutions perceive and t…
Uncategorized
Broadwood Partners遞交最終代理聲明，呼籲STAAR Surgical股東投票「反對」Alcon收購提案
紐約–(BUSINESS WIRE)–(美國商業資訊)– 身為STAAR Surgical Company（簡稱「STAAR」或「公司」）(NASDAQ: STAA)約27.5%已發行普通股的持有者，Broadwood Partners, L.P.及其附屬公司（統稱「Broadwood」）今日宣布已向美國證券交易委員會（簡稱「SEC」）遞交最終代理聲明和綠色代理卡，並就反對Alcon Inc. (NYSE: ALC)附屬公司擬按2025年8月5日公布的條款收購公司（簡稱「擬議合併」）一事致信其…